CD226 or CD155 (intracellular domain)

[{"image":"https://icons.cdn.biorender.com/w75xh75/5e347fdbcf9d2e00289a88ef/5e347f79cf9d2e00289a88da.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e347fdbcf9d2e00289a88ef/5e347f79cf9d2e00289a88da.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e347fdbcf9d2e00289a88ee/5e347f79cf9d2e00289a88da.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e347fdbcf9d2e00289a88ee/5e347f79cf9d2e00289a88da.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e347fdbcf9d2e00289a88ed/5e347f79cf9d2e00289a88da.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e347fdbcf9d2e00289a88ed/5e347f79cf9d2e00289a88da.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e347fdbcf9d2e00289a88ec/5e347f79cf9d2e00289a88da.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e347fdbcf9d2e00289a88ec/5e347f79cf9d2e00289a88da.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e347fdbcf9d2e00289a88eb/5e347f79cf9d2e00289a88da.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e347fdbcf9d2e00289a88eb/5e347f79cf9d2e00289a88da.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e347fdbcf9d2e00289a88ea/5e347f79cf9d2e00289a88da.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e347fdbcf9d2e00289a88ea/5e347f79cf9d2e00289a88da.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e347fdbcf9d2e00289a88e9/5e347f79cf9d2e00289a88da.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e347fdbcf9d2e00289a88e9/5e347f79cf9d2e00289a88da.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e347fdbcf9d2e00289a88e8/5e347f79cf9d2e00289a88da.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e347fdbcf9d2e00289a88e8/5e347f79cf9d2e00289a88da.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e347fdbcf9d2e00289a88e7/5e347f79cf9d2e00289a88da.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e347fdbcf9d2e00289a88e7/5e347f79cf9d2e00289a88da.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e347fdbcf9d2e00289a88e6/5e347f79cf9d2e00289a88da.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e347fdbcf9d2e00289a88e6/5e347f79cf9d2e00289a88da.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e347fdbcf9d2e00289a88e5/5e347f79cf9d2e00289a88da.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e347fdbcf9d2e00289a88e5/5e347f79cf9d2e00289a88da.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e347fdbcf9d2e00289a88e4/5e347f79cf9d2e00289a88da.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e347fdbcf9d2e00289a88e4/5e347f79cf9d2e00289a88da.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e347fdbcf9d2e00289a88e3/5e347f79cf9d2e00289a88da.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e347fdbcf9d2e00289a88e3/5e347f79cf9d2e00289a88da.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e347fdbcf9d2e00289a88e2/5e347f79cf9d2e00289a88da.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e347fdbcf9d2e00289a88e2/5e347f79cf9d2e00289a88da.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e347fdbcf9d2e00289a88e1/5e347f79cf9d2e00289a88da.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e347fdbcf9d2e00289a88e1/5e347f79cf9d2e00289a88da.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e347fdbcf9d2e00289a88e0/5e347f79cf9d2e00289a88da.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e347fdbcf9d2e00289a88e0/5e347f79cf9d2e00289a88da.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e347fdbcf9d2e00289a88df/5e347f79cf9d2e00289a88da.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e347fdbcf9d2e00289a88df/5e347f79cf9d2e00289a88da.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e347fdbcf9d2e00289a88de/5e347f79cf9d2e00289a88da.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e347fdbcf9d2e00289a88de/5e347f79cf9d2e00289a88da.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e347fdbcf9d2e00289a88dd/5e347f79cf9d2e00289a88da.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e347fdbcf9d2e00289a88dd/5e347f79cf9d2e00289a88da.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e347fdbcf9d2e00289a88dc/5e347f79cf9d2e00289a88da.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e347fdbcf9d2e00289a88dc/5e347f79cf9d2e00289a88da.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e347fdbcf9d2e00289a88db/5e347f79cf9d2e00289a88da.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e347fdbcf9d2e00289a88db/5e347f79cf9d2e00289a88da.png"}]